CD5 levels define functionally heterogeneous populations of naïve human CD4


Journal

European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201

Informations de publication

Date de publication:
06 2021
Historique:
revised: 27 12 2020
received: 02 06 2020
accepted: 04 03 2021
pubmed: 9 3 2021
medline: 25 9 2021
entrez: 8 3 2021
Statut: ppublish

Résumé

Studies in murine models show that subthreshold TCR interactions with self-peptide are required for thymic development and peripheral survival of naïve T cells. Recently, differences in the strength of tonic TCR interactions with self-peptide, as read-out by cell surface levels of CD5, were associated with distinct effector potentials among sorted populations of T cells in mice. However, whether CD5 can also be used to parse functional heterogeneity among human T cells is less clear. Our study demonstrates that CD5 levels correlate with TCR signal strength in human naïve CD4

Identifiants

pubmed: 33682083
doi: 10.1002/eji.202048788
pmc: PMC8251777
doi:

Substances chimiques

Autoantigens 0
Biomarkers 0
CD5 Antigens 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1365-1376

Subventions

Organisme : CIHR
ID : MSH-141967
Pays : Canada

Informations de copyright

© 2021 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.

Références

Immunity. 1998 Jun;8(6):675-82
pubmed: 9655481
J Exp Med. 2011 Jun 6;208(6):1279-89
pubmed: 21606508
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18036-41
pubmed: 23071319
Science. 1995 Jul 28;269(5223):535-7
pubmed: 7542801
J Immunol. 1991 Jan 1;146(1):47-52
pubmed: 1701800
Nature. 1994 Jan 20;367(6460):277-81
pubmed: 8121493
Nat Commun. 2013;4:2209
pubmed: 23900386
Nat Immunol. 2014 Mar;15(3):266-74
pubmed: 24487322
J Immunol. 2001 May 1;166(9):5464-72
pubmed: 11313384
Elife. 2015 Jul 14;4:e05949
pubmed: 26173205
J Exp Med. 1998 Dec 21;188(12):2301-11
pubmed: 9858516
Eur J Immunol. 1996 Apr;26(4):738-46
pubmed: 8625962
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9511-6
pubmed: 22645349
Eur J Immunol. 2020 May;50(5):695-704
pubmed: 31943150
Immunology. 1993 Feb;78(2):210-7
pubmed: 7682535
Immunity. 2015 Mar 17;42(3):471-83
pubmed: 25786177
Nat Immunol. 2016 Sep;17(9):1093-101
pubmed: 27478940
Cell Immunol. 1990 Nov;131(1):109-19
pubmed: 1699670
Immunity. 2008 Dec 19;29(6):848-62
pubmed: 19100699
Cell. 2018 Dec 13;175(7):1958-1971.e15
pubmed: 30449619
J Biol Chem. 2003 Mar 7;278(10):8564-71
pubmed: 12473675
Nature. 2002 Nov 28;420(6914):429-34
pubmed: 12459785
Nat Immunol. 2014 Sep;15(9):815-23
pubmed: 25137456
J Immunol. 2015 Sep 1;195(5):2067-79
pubmed: 26195815
Immunol Cell Biol. 2019 Nov;97(10):931-940
pubmed: 31420892
J Immunol. 2017 Jan 15;198(2):657-668
pubmed: 27940659
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15160-15169
pubmed: 31285342
Science. 1997 Jun 27;276(5321):2057-62
pubmed: 9197272
Nat Rev Immunol. 2009 Dec;9(12):823-32
pubmed: 19935802
Eur J Immunol. 2014 Jun;44(6):1866-9
pubmed: 24609896
Eur J Immunol. 2019 Oct;49(10):1457-1973
pubmed: 31633216
Elife. 2017 Dec 14;6:
pubmed: 29239722
JCI Insight. 2018 Jan 25;3(2):
pubmed: 29367462
Immunity. 1996 Sep;5(3):217-28
pubmed: 8808677
Immunity. 2013 Feb 21;38(2):373-83
pubmed: 23395677
Front Immunol. 2018 May 04;9:847
pubmed: 29780381
J Immunol. 2017 Aug 1;199(3):965-973
pubmed: 28659353
Immunity. 2014 Aug 21;41(2):181-90
pubmed: 25148022
J Immunol. 2012 Mar 15;188(6):2537-44
pubmed: 22327072
Nat Immunol. 2015 Jan;16(1):107-17
pubmed: 25419629
Immunity. 2013 Feb 21;38(2):263-274
pubmed: 23290521
Nature. 1994 Jan 20;367(6460):281-4
pubmed: 8121494

Auteurs

Aditi Sood (A)

Immunology-Oncology Unit, Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.

Marie-Ève Lebel (MÈ)

Immunology-Oncology Unit, Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.

Mengqi Dong (M)

Immunology-Oncology Unit, Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.

Marilaine Fournier (M)

Immunology-Oncology Unit, Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada.

Suzanne J Vobecky (SJ)

Service de Chirurgie Cardiaque, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.

Élie Haddad (É)

Département de Pédiatrie, Université de Montréal, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.

Jean-Sébastien Delisle (JS)

Immunology-Oncology Unit, Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada.
Département de Médecine, Université de Montréal, Montreal, Quebec, Canada.

Judith N Mandl (JN)

Department of Physiology, McGill University, Montreal, Quebec, Canada.

Nienke Vrisekoop (N)

Department of Respiratory Medicine, Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

Heather J Melichar (HJ)

Immunology-Oncology Unit, Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada.
Département de Médecine, Université de Montréal, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH